Alpha-defensin 5 differentially modulates adenovirus vaccine vectors from different serotypes in vivo

English version

Autoři: Lawrence J. Tartaglia ^aff001; Alexander Badamchi-Zadeh ^aff001; Peter Abbink ^aff001; Eryn Blass ^aff001; Malika Aid ^aff001; Makda S. Gebre ^aff001; Zhenfeng Li ^aff001; Kevin Clyde Pastores ^aff001; Sebastien Trott ^aff001; Siddhant Gupte ^aff001; Rafael A. Larocca ^aff001; Dan H. Barouch ^aff001
Působiště autorů: Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston Massachusetts, United States of America ^aff001; Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, United States of America ^aff002
Vyšlo v časopise: Alpha-defensin 5 differentially modulates adenovirus vaccine vectors from different serotypes in vivo. PLoS Pathog 15(12): e32767. doi:10.1371/journal.ppat.1008180
Kategorie: Research Article
doi: https://doi.org/10.1371/journal.ppat.1008180

Souhrn

Adenoviral vectors have shown significant promise as vaccine delivery vectors due to their ability to elicit both innate and adaptive immune responses. α-defensins are effector molecules of the innate immune response and have been shown to modulate natural infection with adenoviruses, but the majority of α-defensin-adenovirus interactions studied to date have only been analyzed in vitro. In this study, we evaluated the role of α-defensin 5 (HD5) in modulating adenovirus vaccine immunogenicity using various serotype adenovirus vectors in mice. We screened a panel of human adenoviruses including Ad5 (species C), Ad26 (species D), Ad35 (species B), Ad48 (species D) and a chimeric Ad5HVR48 for HD5 sensitivity. HD5 inhibited transgene expression from Ad5 and Ad35 but augmented transgene expression from Ad26, Ad48, and Ad5HVR48. HD5 similarly suppressed antigen-specific IgG and CD8⁺ T cell responses elicited by Ad5 vectors in mice, but augmented IgG and CD8⁺ T cell responses and innate cytokine responses elicited by Ad26 vectors in mice. Moreover, HD5 suppressed the protective efficacy of Ad5 vectors but enhanced the protective efficacy of Ad26 vectors expressing SIINFEKL against a surrogate Listeria-OVA challenge in mice. These data demonstrate that HD5 differentially modulates adenovirus vaccine delivery vectors in a species-specific manner in vivo.

Klíčová slova:

Adenoviruses – Antigens – Cytokines – Cytotoxic T cells – Enzyme-linked immunoassays – Immune response – T cells – Vaccines

Zdroje

1. Gursoy UK, Könönen E, Luukkonen N, Uitto V-J. Human neutrophil defensins and their effect on epithelial cells. J Periodontol. 2013 Jan;84(1):126–33. doi: 10.1902/jop.2012.120017 22443519

2. Cunliffe RN. Alpha-defensins in the gastrointestinal tract. Mol Immunol. 2003 Nov;40(7):463–7. doi: 10.1016/s0161-5890(03)00157-3 14568393

3. Tenge VR, Gounder AP, Wiens ME, Lu W, Smith JG. Delineation of interfaces on human alpha-defensins critical for human adenovirus and human papillomavirus inhibition. PLoS Pathog. 2014 Sep;10(9):e1004360. doi: 10.1371/journal.ppat.1004360 25188351

4. Lehrer RI, Lu W. α-Defensins in human innate immunity. Immunol Rev. 2012 Jan;245(1):84–112. doi: 10.1111/j.1600-065X.2011.01082.x 22168415

5. Smith JG, Silvestry M, Lindert S, Lu W, Nemerow GR, Stewart PL. Insight into the mechanisms of adenovirus capsid disassembly from studies of defensin neutralization. PLoS Pathog. 2010 Jan 1;6(6):e1000959–9. doi: 10.1371/journal.ppat.1000959 20585634

6. Smith JG, Nemerow GR. Mechanism of adenovirus neutralization by Human alpha-defensins. Cell Host Microbe. 2008 Jan 17;3(1):11–9. doi: 10.1016/j.chom.2007.12.001 18191790

7. Wilson SS, Wiens ME, Smith JG. Antiviral mechanisms of human defensins. J Mol Biol. 2013 Dec 13;425(24):4965–80. doi: 10.1016/j.jmb.2013.09.038 24095897

8. Wilson SS, Bromme BA, Holly MK, Wiens ME, Gounder AP, Sul Y, et al. Alpha-defensin-dependent enhancement of enteric viral infection. PLoS Pathog. 2017 Jun;13(6):e1006446. doi: 10.1371/journal.ppat.1006446 28622386

9. Gounder AP, Myers ND, Treuting PM, Bromme BA, Wilson SS, Wiens ME, et al. Defensins Potentiate a Neutralizing Antibody Response to Enteric Viral Infection. PLoS Pathog. 2016 Mar;12(3):e1005474. doi: 10.1371/journal.ppat.1005474 26933888

10. Brogden KA, Heidari M, Sacco RE, Palmquist D, Guthmiller JM, Johnson GK, et al. Defensin-induced adaptive immunity in mice and its potential in preventing periodontal disease. Oral Microbiol Immunol. 2003 Apr;18(2):95–9. doi: 10.1034/j.1399-302x.2003.00047.x 12654098

11. Kim S-H, Yang I-Y, Kim J, Lee K-Y, Jang Y-S. Antimicrobial peptide LL-37 promotes antigen-specific immune responses in mice by enhancing Th17-skewed mucosal and systemic immunities. Eur J Immunol. 2015 May;45(5):1402–13. doi: 10.1002/eji.201444988 25655317

12. Cao D, Li H, Jiang Z, Cheng Q, Yang Z, Xu C, et al. CpG oligodeoxynucleotide synergizes innate defense regulator peptide for enhancing the systemic and mucosal immune responses to pseudorabies attenuated virus vaccine in piglets in vivo. Int Immunopharmacol. 2011 Jun;11(6):748–54. doi: 10.1016/j.intimp.2011.01.028 21310256

13. Achtman AH, Pilat S, Law CW, Lynn DJ, Janot L, Mayer ML, et al. Effective adjunctive therapy by an innate defense regulatory peptide in a preclinical model of severe malaria. Sci Transl Med. 2012 May 23;4(135):135ra64.

14. Kindrachuk J, Jenssen H, Elliott M, Townsend R, Nijnik A, Lee SF, et al. A novel vaccine adjuvant comprised of a synthetic innate defence regulator peptide and CpG oligonucleotide links innate and adaptive immunity. Vaccine. 2009 Jul 23;27(34):4662–71. doi: 10.1016/j.vaccine.2009.05.094 19539585

15. Hemshekhar M, Anaparti V, Mookherjee N. Functions of Cationic Host Defense Peptides in Immunity. Pharmaceuticals (Basel. 2016 Jul 4;9(3).

16. Abbink P, Lemckert AAC, Ewald BA, Lynch DM, Denholtz M, Smits S, et al. Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D. J Virol. 2007 May;81(9):4654–63. doi: 10.1128/JVI.02696-06 17329340

17. Vragniau C, Hübner J-M, Beidler P, Gil S, Saydaminova K, Lu Z-Z, et al. Studies on the Interaction of Tumor-Derived HD5 Alpha Defensins with Adenoviruses and Implications for Oncolytic Adenovirus Therapy. J Virol. 2017 Mar 15;91(6).

18. Flatt JW, Kim R, Smith JG, Nemerow GR, Stewart PL. An intrinsically disordered region of the adenovirus capsid is implicated in neutralization by human alpha defensin 5. PLoS ONE. 2013;8(4):e61571. doi: 10.1371/journal.pone.0061571 23620768

19. Bradley RR, Lynch DM, Iampietro MJ, Borducchi EN, Barouch DH. Adenovirus serotype 5 neutralizing antibodies target both hexon and fiber following vaccination and natural infection. J Virol. 2012 Jan;86(1):625–9. doi: 10.1128/JVI.06254-11 22072776

20. Bradley RR, Maxfield LF, Lynch DM, Iampietro MJ, Borducchi EN, Barouch DH. Adenovirus serotype 5-specific neutralizing antibodies target multiple hexon hypervariable regions. J Virol. 2012 Jan;86(2):1267–72. doi: 10.1128/JVI.06165-11 22072746

21. Roberts DM, Nanda A, Havenga MJE, Abbink P, Lynch DM, Ewald BA, et al. Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity. Nature. 2006 May 11;441(7090):239–43. doi: 10.1038/nature04721 16625206

22. Zhang Y, Chirmule N, Gao GP, Qian R, Croyle M, Joshi B, et al. Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages. Mol Ther. 2001 May;3(5 Pt 1):697–707.

23. Teigler JE, Iampietro MJ, Barouch DH. Vaccination with adenovirus serotypes 35, 26, and 48 elicits higher levels of innate cytokine responses than adenovirus serotype 5 in rhesus monkeys. J Virol. 2012 Sep;86(18):9590–8. doi: 10.1128/JVI.00740-12 22787208

24. Kohlgraf KG, Pingel LC, Dietrich DE, Brogden KA. Defensins as anti-inflammatory compounds and mucosal adjuvants. Future Microbiol. 2010 Jan;5(1):99–113. doi: 10.2217/fmb.09.104 20020832

25. Provine NM, Larocca RA, Penaloza-MacMaster P, Borducchi EN, McNally A, Parenteau LR, et al. Longitudinal requirement for CD4+ T cell help for adenovirus vector-elicited CD8+ T cell responses. J Immunol. 2014 Jun 1;192(11):5214–25. doi: 10.4049/jimmunol.1302806 24778441

26. Penaloza-MacMaster P, Teigler JE, Obeng RC, Kang ZH, Provine NM, Parenteau L, et al. Augmented replicative capacity of the boosting antigen improves the protective efficacy of heterologous prime-boost vaccine regimens. J Virol. 2014 Jun;88(11):6243–54. doi: 10.1128/JVI.00406-14 24648461

27. Im E-J, Borducchi EN, Provine NM, McNally AG, Li S, Frankel FR, et al. An attenuated Listeria monocytogenes vector primes more potent simian immunodeficiency virus-specific mucosal immunity than DNA vaccines in mice. J Virol. 2013 Apr;87(8):4751–5. doi: 10.1128/JVI.03085-12 23388715

28. Sarfraz M, Suleman M, Tikoo SK, Wheler C, Potter AA, Gerdts V, et al. Immune responses to in ovo vaccine formulations containing inactivated fowl adenovirus 8b with poly[di(sodium carboxylatoethylphenoxy)]phosphazene (PCEP) and avian beta defensin as adjuvants in chickens. Vaccine. 2017 Feb 7;35(6):981–6. doi: 10.1016/j.vaccine.2016.12.023 28087147

29. Mastroianni JR, Ouellette AJ. Alpha-defensins in enteric innate immunity: functional Paneth cell alpha-defensins in mouse colonic lumen. J Biol Chem. 2009 Oct 9;284(41):27848–56. doi: 10.1074/jbc.M109.050773 19687006

30. Lillard JW, Boyaka PN, Chertov O, Oppenheim JJ, McGhee JR. Mechanisms for induction of acquired host immunity by neutrophil peptide defensins. Proc Natl Acad Sci U S A. 1999 Jan 19;96(2):651–6. doi: 10.1073/pnas.96.2.651 9892688

31. Tani K, Murphy WJ, Chertov O, Salcedo R, Koh CY, Utsunomiya I, et al. Defensins act as potent adjuvants that promote cellular and humoral immune responses in mice to a lymphoma idiotype and carrier antigens. Int Immunol. 2000 May;12(5):691–700. doi: 10.1093/intimm/12.5.691 10784615

32. Curtsinger JM, Schmidt CS, Mondino A, Lins DC, Kedl RM, Jenkins MK, et al. Inflammatory cytokines provide a third signal for activation of naive CD4+ and CD8+ T cells. J Immunol. 1999 Mar 15;162(6):3256–62. 10092777

33. Arcasoy SM, Latoche JD, Gondor M, Pitt BR, Pilewski JM. Polycations increase the efficiency of adenovirus-mediated gene transfer to epithelial and endothelial cells in vitro. Gene Ther. 1997 Jan;4(1):32–8. doi: 10.1038/sj.gt.3300349 9068793

34. Kaplan JM, Pennington SE, St George JA, Woodworth LA, Fasbender A, Marshall J, et al. Potentiation of gene transfer to the mouse lung by complexes of adenovirus vector and polycations improves therapeutic potential. Hum Gene Ther. 1998 Jul 1;9(10):1469–79. doi: 10.1089/hum.1998.9.10-1469 9681418

35. Chillón M, Lee JH, Fasbender A, Welsh MJ. Adenovirus complexed with polyethylene glycol and cationic lipid is shielded from neutralizing antibodies in vitro. Gene Ther. 1998 Jul;5(7):995–1002. doi: 10.1038/sj.gt.3300665 9813671

36. Qiu C, De Young MB, Finn A, Dichek DA. Cationic liposomes enhance adenovirus entry via a pathway independent of the fiber receptor and alpha(v)-integrins. Hum Gene Ther. 1998 Mar 1;9(4):507–20. doi: 10.1089/hum.1998.9.4-507 9525312

37. Dodds E, Piper TA, Murphy SJ, Dickson G. Cationic lipids and polymers are able to enhance adenoviral infection of cultured mouse myotubes. J Neurochem. 1999 May;72(5):2105–12. doi: 10.1046/j.1471-4159.1999.0722105.x 10217291

38. Zhao C, Wu N, Deng F, Zhang H, Wang N, Zhang W, et al. Adenovirus-mediated gene transfer in mesenchymal stem cells can be significantly enhanced by the cationic polymer polybrene. PLoS ONE. 2014;9(3):e92908. doi: 10.1371/journal.pone.0092908 24658746

39. Kaufman DR, Bivas-Benita M, Simmons NL, Miller D, Barouch DH. Route of adenovirus-based HIV-1 vaccine delivery impacts the phenotype and trafficking of vaccine-elicited CD8+ T lymphocytes. J Virol. 2010 Jun;84(12):5986–96. doi: 10.1128/JVI.02563-09 20357087

40. Quigley M, Pereyra F, Nilsson B, Porichis F, Fonseca C, Eichbaum Q, et al. Transcriptional analysis of HIV-specific CD8+ T cells shows that PD-1 inhibits T cell function by upregulating BATF. Nat Med. 2010 Oct;16(10):1147–51. doi: 10.1038/nm.2232 20890291

41. Provine NM, Larocca RA, Aid M, Penaloza-MacMaster P, Badamchi-Zadeh A, Borducchi EN, et al. Immediate Dysfunction of Vaccine-Elicited CD8+ T Cells Primed in the Absence of CD4+ T Cells. J Immunol. 2016 Sep 1;197(5):1809–22. doi: 10.4049/jimmunol.1600591 27448585

42. Barouch DH, Pau MG, Custers J. Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity. The Journal of Immunol. 2004 May;172(10):6290–7

43. Provine NM, Badamchi-Zadeh A, Bricault CA, Penaloza-MacMaster P, Larocca RA, Borducchi EN, et al. Transient CD4+ T Cell Depletion Results in Delayed Development of Functional Vaccine-Elicited Antibody Responses. J Virol. 2016 May;90(9):4278–88. doi: 10.1128/JVI.00039-16 26865713

44. Rötzschke O, Falk K, Stevanović S, Jung G, Walden P, Rammensee HG. Exact prediction of a natural T cell epitope. Eur J Immunol. 1991 Nov;21(11):2891–4. doi: 10.1002/eji.1830211136 1718764

45. Shen H, Slifka MK, Matloubian M, Jensen ER, Ahmed R, Miller JF. Recombinant Listeria monocytogenes as a live vaccine vehicle for the induction of protective anti-viral cell-mediated immunity. Proc Natl Acad Sci U S A. 1995 Apr 25;92(9):3987–91. doi: 10.1073/pnas.92.9.3987 7732018